Pier Capital Lowers stake in West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST) : Pier Capital reduced its stake in West Pharmaceutical Services by 3.18% during the most recent quarter end. The investment management company now holds a total of 102,082 shares of West Pharmaceutical Services which is valued at $8,268,642 after selling 3,351 shares in West Pharmaceutical Services , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.West Pharmaceutical Services makes up approximately 1.40% of Pier Capital’s portfolio.

Other Hedge Funds, Including , Mount Lucas Management Lp added WST to its portfolio by purchasing 3,079 company shares during the most recent quarter which is valued at $249,399. West Pharmaceutical Services makes up approx 0.04% of Mount Lucas Management Lp’s portfolio.Southeast Asset Advisors reduced its stake in WST by selling 60 shares or 0.64% in the most recent quarter. The Hedge Fund company now holds 9,290 shares of WST which is valued at $752,490. West Pharmaceutical Services makes up approx 0.25% of Southeast Asset Advisors’s portfolio.Mufg Americas Holdings Corp boosted its stake in WST in the latest quarter, The investment management firm added 378 additional shares and now holds a total of 668 shares of West Pharmaceutical Services which is valued at $54,369. Lmr Partners Llp added WST to its portfolio by purchasing 48,716 company shares during the most recent quarter which is valued at $3,910,920. West Pharmaceutical Services makes up approx 0.59% of Lmr Partners Llp’s portfolio.

West Pharmaceutical Services closed down -0.1 points or -0.12% at $81.73 with 2,76,616 shares getting traded on Thursday. Post opening the session at $82.07, the shares hit an intraday low of $81.4 and an intraday high of $82.15 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *